Hemoglobin H disease due to a de novo mutation at the α2-globin gene and an inherited common α-thalassemia deletion found in a Chinese boy

Blood Cells Mol Dis. 2010 Oct 15;45(3):223-6. doi: 10.1016/j.bcmd.2010.07.005. Epub 2010 Aug 6.

Abstract

Hemoglobin (Hb) H disease is a moderate form of α-thalassemia resulting from various genetic defects. A novel frameshift mutation cd 43/44(-C) at the α2-globin gene was identified in a Chinese boy with hemoglobin H disease by sequencing. The proband's mother carries a common α-thalassemia deletion while his father was normal both in the hematological phenotype and α-globin genotype, which suggested that it occurred as a de novo mutation. Molecular studies revealed a compound heterozygote for the Southeast Asian α-thalassemia deletion and this novel spontaneous mutation (-/α(T)α) and the patient exhibited the clinical manifestation of classic hemoglobin H disease. Based on the results of excluding the possibility of a somatic mosaicism of a point mutation in the α2-globin gene, we progress that this de novo single-base deletion should have arisen during the spermatogenic process or earlier embryonic stage. The present study provides information in determining a supplementary model of inheritance for α-thalassemia, which should be useful in genetic counseling.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Asian People
  • China
  • Fathers
  • Female
  • Frameshift Mutation*
  • Genetic Counseling
  • Heterozygote
  • Humans
  • Infant
  • Male
  • Models, Genetic
  • Mosaicism
  • Mothers
  • alpha-Globins / genetics*
  • alpha-Thalassemia / genetics*
  • alpha-Thalassemia / pathology

Substances

  • alpha-Globins